NOS1 and migraine disorder: The involvement of endogenous NO in migraine pathophysiology was confirmed by the anti-migraine effect of the nitric oxide synthase (NOS) inhibitor L-NG-monomethyl arginine citrate (L-NMMA) [7,8].